Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

175.25 -0.83 (-0.47%)

Streaming Delayed Price Updated: 1:49 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among...

Via Talk Markets

Topics Initial Public Offering

The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...

Via Benzinga

Topics Initial Public Offering

GW Pharmaceuticals' Cannabidiol For Seizures Wins UK Approval ↗

August 10, 2021

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals' cannabidiol as an adjunctive treatment of seizures...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Where Jazz Pharmaceuticals Stands With Analysts ↗

June 22, 2021

Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Watch Medical Marijuana & Unrivaled Brands At The Benzinga Cannabis Hour ↗

August 06, 2021

Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday's show, hosts ...

Via Benzinga

Topics Cannabis

Cannabis Daily Podcast 8/5: Europe Expansion And Buy The Dip Opportunity Stocks ↗

August 05, 2021

Start The Day With The Best Daily Pre-Market Overview Of The Can...

Via Benzinga

Topics Cannabis

Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments

August 05, 2021

Via FinancialNewsMedia

Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript ↗

August 03, 2021

JAZZ earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Jazz Pharmaceuticals Q2 Earnings ↗

August 03, 2021

Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 5.12% over the past...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates ↗

August 02, 2021

The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...

Via Benzinga

Jazz Pharmaceuticals's Earnings: A Preview ↗

August 02, 2021

Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2...

Via Benzinga

Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So. ↗

July 29, 2021

Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regula...

Via Benzinga

Topics Cannabis

Is Jazz Pharmaceuticals Stock a Buy? ↗

July 24, 2021

Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look.

Via The Motley Fool

The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More ↗

July 02, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs...

Via Benzinga

Topics Cannabis

Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June ↗

July 02, 2021

The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down...

Via Benzinga

Topics Cannabis

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer ↗

July 01, 2021

The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic...

Via Benzinga

Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys ↗

June 29, 2021

They are great options whether you are investing for the short or long term.

Via The Motley Fool

Topics Cannabis

Finding Value In Mid-Cap Stocks ↗

June 24, 2021

Within the mid-cap space there is something for everyone.

Via Talk Markets

New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End ↗

June 24, 2021

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...

Via Benzinga

14 Biotech Stocks To Watch Over The Next 6 Months ↗

June 23, 2021

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

June 22, 2021

Goldman Sachs lowered Casey's General Stores, Inc. (NASDAQ:

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

June 21, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 21, 2021

SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

June 18, 2021

Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading. SVB Leerink boosted Jazz...

Via Benzinga

Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition ↗

June 17, 2021

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Delivering useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/pages/Cabling-Installation-and-Maintenance/298118662118

https://www.instagram.com/cim_magazine/

https://www.linkedin.com/company/3962332

http://twitter.com/CABLINGMAG

Affiliated Brands

DATA CENTER FRONTIER

ISE

LIGHTWAVE

DIGITAL INFRASTRUCTURE GROUP

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions